Boceprevir for previously treated chronic HCV genotype 1 infection - Test2 - elhamkhani - TriplyDB

Boceprevir for previously treated chronic HCV genotype 1 infection

Boceprevir for previously treated chronic HCV genotype 1 infection

http://www.wikidata.org/entity/Q24620576

about

Direct-acting antivirals for the treatment of chronic hepatitis C: open issues and future perspectives Direct-acting antivirals for chronic hepatitis C Aminoadamantanes versus other antiviral drugs for chronic hepatitis C Aminoadamantanes for chronic hepatitis C Aminoadamantanes versus other antiviral drugs for chronic hepatitis C Aminoadamantanes for chronic hepatitis C Review and management of drug interactions with boceprevir and telaprevir Hepatitis C virus protease inhibitor-resistance mutations: our experience and review An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Antiviral drugs for viruses other than human immunodeficiency virus A Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C Virus Management of HCV-Associated Liver Cirrhosis.Conceptual framework for outcomes research studies of hepatitis C: an analytical review Recent Advances in Antiviral Therapy for Chronic Hepatitis C Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis Treating hepatitis C - what's new?Sofosbuvir treatment and hepatitis C virus infection Advances in hepatitis C therapy: What is the current state - what come's next?Alcoholic liver disease and hepatitis C virus infection Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C Oxidative stress modulation in hepatitis C virus infected cells Chronic hepatitis C: This and the new era of treatment Hepatitis C genotype 4: The past, present, and future Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes Era of direct acting antivirals in chronic hepatitis C: Who will benefit?Chronic Hepatitis C Infection in Children: Current Treatment and New Therapies Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management Impact of new treatment options for hepatitis C virus infection in liver transplantation Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals Hepatitis C: Treatment of difficult to treat patients Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications New era for management of chronic hepatitis C virus using direct antiviral agents: A review Finally sofosbuvir: an oral anti-HCV drug with wide performance capability Chronic hepatitis C: future treatment Natural history and clinical response: "it's the virus, stupid, or is it the host?"Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus Oral antiviral therapies for chronic hepatitis C infection Antiviral treatment of hepatitis C virus infection and factors affecting efficacy Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy

P2860

Q21265028-B5C337DE-58F0-486F-9964-D3543E596F27 Q24185977-8FA1498C-1293-4410-9159-945CB77A08A3 Q24193940-47C99C42-7CFF-44CC-8F20-02B1C79B83D3 Q24194770-BF5631AF-A136-4C85-8C77-80CC0FBE58A3 Q24194815-92D13739-E45F-4CBD-B807-4ACC95CAD865 Q24201226-7CBA9539-3538-4447-AFBB-75E23D87F903 Q24628716-D71B74EF-7147-45DC-AED8-2BBB7840DD5D Q24628717-EBF96363-F460-42D9-8195-0572AD17DAFF Q24632766-96E6006E-C182-4464-8B38-BABEEC87AE9F Q24635330-7CA95DC6-0846-48D5-BC27-B04F651CAAAA Q26700115-9708527C-FED6-4803-ACEC-04255A56E1F4 Q26740320-15AE40CD-CBA6-40DE-A86F-F9EC94E138A3 Q26745582-78FF15C7-65DC-49B5-9C85-0ECA2C20EFF2 Q26750476-63776BF8-503B-4C89-9BD5-BC7F9B27A8D8 Q26752433-6F93D0B4-32FD-4C24-BB33-0A7A676DF3EE Q26765752-F2F85B96-E423-4DF9-8CC4-4D71A21CCE0B Q26769646-B0E766AC-B605-4B9D-BB84-4CA58BB5AA48 Q26770024-4D235797-EE1C-4391-B019-40FCC6C5D437 Q26770036-40EE059B-058B-4D15-BD6A-8048BD7BA26E Q26773274-C0CF45C6-6DA7-4ED3-A681-1F39C20C6D9F Q26773283-FE93305C-74DF-4787-97C7-5F19F888AEE6 Q26774003-43DF8048-CCBE-4C3D-9A94-58994CD5DD61 Q26775011-422AA42F-22BE-454A-B9D3-AD72E98FC5AA Q26775815-779EE8A0-CAF2-4C3D-BDB3-C796021219EF Q26777086-68585B17-272D-4575-B8CA-6E65484FF957 Q26777506-BFDDF78F-CBCE-43EB-A4F5-171718C6E093 Q26781770-187344A7-D31F-4622-87A5-3C61619AFC8E Q26781984-B04390EC-ACEC-42F4-8625-1D57C1293F39 Q26782017-EDA06BA0-93B1-436C-83A6-92A24B05DFD0 Q26782033-81D0027C-9ACF-4219-8DB3-FF9FDF203D8A Q26798465-C26BA946-BEF4-4BEB-A558-6A33AD08A12E Q26798477-AD8C99F5-9D95-45F0-9588-475EC546E4ED Q26800050-7154988B-5589-4619-86A9-BD8EA4CCE29A Q26822400-73A046E1-C085-4D23-9243-A2E7AA2FF2FA Q26824075-48D07647-D06B-4013-8F49-5EED0DE97011 Q26824094-B917A92F-A807-4455-A1D2-044456ED813C Q26830190-86A0C50A-3BBA-486D-AB4B-88244EBC4EAC Q26830426-7300F13B-2A6C-4554-9EA0-E0015DDF1AD7 Q26851810-9542D8F1-812A-4C94-B460-413B55625F59 Q26853500-140E8BAF-87EB-48E7-9EF5-36ADA29AC8A6

P2860

Boceprevir for previously treated chronic HCV genotype 1 infection

http://www.wikidata.org/entity/Q24620576

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Boceprevir for previously treated chronic HCV genotype 1 infection

@ast

Boceprevir for previously treated chronic HCV genotype 1 infection

@en

Boceprevir for previously treated chronic HCV genotype 1 infection

@nl

type

label

Boceprevir for previously treated chronic HCV genotype 1 infection

@ast

Boceprevir for previously treated chronic HCV genotype 1 infection

@en

Boceprevir for previously treated chronic HCV genotype 1 infection

@nl

prefLabel

Boceprevir for previously treated chronic HCV genotype 1 infection

@ast

Boceprevir for previously treated chronic HCV genotype 1 infection

@en

Boceprevir for previously treated chronic HCV genotype 1 infection

@nl

P1433

Q24620576-443A7ABC-0ECA-4102-96E6-858F08CF736D

P1476

Q24620576-C5FBC1F2-3996-46CE-82D6-43D19676B5B1

P2093

Q24620576-13732C09-88F2-4ED0-A97F-E9D7BBF10F2B

Q24620576-5DF627AC-B42D-4A78-B8F7-63BE777EF234

Q24620576-82B040A2-4BD7-4255-B0D4-01A9A8D9C5C8

Q24620576-878B1E5B-654C-4A36-B70B-3CA870286896

Q24620576-95FA4C11-CA24-428D-A442-8940689C3139

Q24620576-9B5A88BF-7F0E-46D3-A699-000C860DD740

Q24620576-9CD2E6AA-6776-4723-B26F-E624B0112F94

Q24620576-C4D4AB22-2762-4965-A9FC-B9E62A270C79

Q24620576-C6703340-1EB0-479C-AA52-3516A3AFF06D

Q24620576-DC42B831-871A-4090-AFB6-F9C15A525F20

P2860

Q24620576-0A59790E-7348-42FE-A80F-01A20529074D

Q24620576-0C123F2D-230A-4017-B704-F9AA437F7FF7

Q24620576-1BD03350-76B1-4C1A-8767-74BD8DD365ED

Q24620576-27F99AAF-EC49-48BA-9FFF-7A4A0BF2137C

Q24620576-2F964DAB-8344-493D-85CD-963F5408D38A

Q24620576-3A1BE8F6-AEC3-4CA8-A71E-576856EEA127

Q24620576-46D46626-1CEE-4459-931D-A282ADBA5AE5

Q24620576-57D69F90-1395-4A63-AF71-F8E90A688318

Q24620576-684C2E11-20AC-4E5B-8836-AD1F121253A0

Q24620576-6B3FCF60-666B-418D-9B99-EF776A5EC63F

P304

Q24620576-4A3D2E90-872F-4CE8-AE15-8A8D1D63D0FA

P31

Q24620576-096A6CF4-3D6B-4B68-9419-7BC075080AD8

P3181

Q24620576-2A58A11E-3811-412B-87FB-A0858E8E298D

P356

Q24620576-0EB6F19E-E14D-46B7-A233-18D647488EBB

P407

Q24620576-0AD1EFDD-01AE-4A0F-AF55-6DFBDAB7C073

P433

Q24620576-E4015E44-7364-43FD-A098-54DF13739185

P478

Q24620576-7E3325F8-DAD7-41CB-A278-9217BEF0715E

P50

Q24620576-1928E733-F0EF-4B88-8C62-6245C4451626

Q24620576-389830DC-FF3B-466E-B89F-8383E7C9F577

Q24620576-47370BFF-C297-453E-99FB-B7DD17B52A9A

P577

Q24620576-9FFFBE6E-A27E-4AD4-A12B-C6050C2B0761

P698

Q24620576-27CF5D7E-10B2-4DF3-A8A8-B5F157D49E68

P932

Q24620576-CBF01D30-9796-4258-82F1-78376C588740

P3181

P356

P1433

The New England Journal of Medicine

P1476

Boceprevir for previously treated chronic HCV genotype 1 infection

@en

P2093

Bruce R Bacon

http://www.w3.org/2001/XMLSchema#string

Clifford A Brass

http://www.w3.org/2001/XMLSchema#string

Eric Lawitz

http://www.w3.org/2001/XMLSchema#string

Heather L Sings

http://www.w3.org/2001/XMLSchema#string

Janice K Albrecht

http://www.w3.org/2001/XMLSchema#string

John M Vierling

http://www.w3.org/2001/XMLSchema#string

Margaret Burroughs

http://www.w3.org/2001/XMLSchema#string

Navdeep Boparai

http://www.w3.org/2001/XMLSchema#string

Patrick Marcellin

http://www.w3.org/2001/XMLSchema#string

Stuart C Gordon

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of the TRUGENE HCV 5'NC Genotyping Kit with the New GeneLibrarian Module 3.1.2 for Genotyping of Hepatitis C Virus from Clinical Specimens

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

Boceprevir for untreated chronic HCV genotype 1 infection

Telaprevir for previously treated chronic HCV infection.

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

Peginterferon and ribavirin for chronic hepatitis C.

Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms.

P304

1207-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

363182

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1009482

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

364

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21449784

http://www.w3.org/2001/XMLSchema#string

P932

3153125

http://www.w3.org/2001/XMLSchema#string